
Clinical Development of Cyclin-Dependent Kinase Inhibitors in Lung Cancer
Published: | Updated:
This manuscript focuses on the latest clinical developments of newer generation selective CDK inhibitors in lung cancer.

This manuscript focuses on the latest clinical developments of newer generation selective CDK inhibitors in lung cancer.

Published: March 2nd 2017 | Updated: April 18th 2020